Poseida Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 02/13/2025 | 10.01 M | $96.11 M | -31.29% | 10.30% |
PENTWATER CAPITAL MANAGEMENT LP | 02/14/2025 | 8.63 M | $82.80 M | 44.35% | 8.88% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.63 M | $54.06 M | 9.90% | 5.80% |
NOMURA HOLDINGS INC | 02/14/2025 | 5.12 M | $49.10 M | 100.00% | 5.26% |
VANGUARD GROUP INC | 02/11/2025 | 3.83 M | $36.81 M | 4.67% | 3.95% |
ALPINE ASSOCIATES MANAGEMENT INC. | 02/07/2025 | 2.02 M | $19.36 M | 100.00% | 2.08% |
02/14/2025 | 2.00 M | $19.20 M | 100.00% | 2.06% | |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.63 M | $15.65 M | 0.78% | 1.68% |
STATE STREET CORP | 02/14/2025 | 1.59 M | $15.31 M | -6.78% | 1.64% |
AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 1.04 M | $10.02 M | 0.00% | 1.07% |
SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.01 M | $9.72 M | -72.55% | 1.04% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 933,102 | $8.96 M | 12.28% | 0.96% |
TIG ADVISORS, LLC | 02/14/2025 | 685,595 | $6.58 M | 100.00% | 0.71% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 589,007 | $5.65 M | 3.87% | 0.61% |
GLAZER CAPITAL, LLC | 02/14/2025 | 521,113 | $5.00 M | 100.00% | 0.54% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 463,683 | $4.45 M | -17.66% | 0.48% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 02/12/2025 | 400,000 | $3.84 M | 100.00% | 0.41% |
TRIUM CAPITAL LLP | 01/15/2025 | 386,407 | $3.71 M | 100.00% | 0.40% |
683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 350,000 | $3.36 M | 100.00% | 0.36% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 339,715 | $3.26 M | 10.17% | 0.35% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 322,060 | $3.09 M | -46.97% | 0.33% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 299,297 | $2.87 M | -1.74% | 0.31% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 271,200 | $2.60 M | -69.79% | 0.28% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 246,800 | $2.37 M | 100.00% | 0.25% |
OMERS ADMINISTRATION CORP | 02/14/2025 | 224,000 | $2.15 M | 100.00% | 0.23% |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/12/2025 | 223,990 | $2.15 M | -36.25% | 0.23% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 201,957 | $1.94 M | 23.07% | 0.21% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 198,375 | $1.90 M | 100.00% | 0.20% |
YAKIRA CAPITAL MANAGEMENT, INC. | 02/13/2025 | 177,404 | $1.70 M | 100.00% | 0.18% |
JPMORGAN CHASE & CO | 02/12/2025 | 176,956 | $1.70 M | 181.11% | 0.18% |
WALLEYE CAPITAL LLC | 02/13/2025 | 172,459 | $1.66 M | 100.00% | 0.18% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 153,058 | $1.47 M | -57.39% | 0.16% |
DELTEC ASSET MANAGEMENT LLC | 01/27/2025 | 150,000 | $1.44 M | 100.00% | 0.15% |
MARSHALL WACE, LLP | 02/13/2025 | 146,232 | $1.40 M | 263.82% | 0.15% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 141,339 | $1.36 M | -6.68% | 0.15% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 136,116 | $1.31 M | -93.80% | 0.14% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 134,109 | $1.29 M | 100.00% | 0.14% |
EQUITEC PROPRIETARY MARKETS, LLC | 01/29/2025 | 124,200 | $1.19 M | 100.00% | 0.13% |
UBS GROUP AG | 02/14/2025 | 120,549 | $1.16 M | 72.91% | 0.12% |
02/14/2025 | 120,000 | $1.15 M | 100.00% | 0.12% | |
RHUMBLINE ADVISERS | 01/30/2025 | 113,431 | $1.09 M | 8.55% | 0.12% |
BARCLAYS PLC | 02/13/2025 | 104,822 | $1.01 M | -12.98% | 0.11% |
DEKABANK DEUTSCHE GIROZENTRALE | 01/29/2025 | 100,000 | $913,000 | 0.00% | 0.10% |
02/12/2025 | 97,300 | $934,080 | 100.00% | 0.10% | |
ATOM INVESTORS LP | 02/14/2025 | 82,856 | $795,418 | 100.00% | 0.09% |
HARVEST MANAGEMENT LLC | 02/14/2025 | 80,000 | $768,000 | 100.00% | 0.08% |
02/24/2025 | 80,000 | $768,000 | 100.00% | 0.08% | |
EQUITEC PROPRIETARY MARKETS, LLC | 01/29/2025 | 74,100 | $711,360 | 100.00% | 0.08% |
XTX TOPCO LTD | 02/13/2025 | 71,040 | $681,984 | -61.16% | 0.07% |
RBF CAPITAL, LLC | 02/14/2025 | 70,171 | $673,642 | 0.00% | 0.07% |
Poseida Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 136 institutional investors and hedge funds held shares of Poseida Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 10.01 M
Pentwater Capital Management LP: 8.63 M
BlackRock Funding, Inc. /DE: 5.63 M
NOMURA HOLDINGS INC: 5.12 M
VANGUARD GROUP INC: 3.83 M
ALPINE ASSOCIATES MANAGEMENT INC.: 2.02 M
55.14% of Poseida Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 59.34 M shares in the last 24 months. This purchase volume represents approximately $567.28 M in transactions.